(Q46985103)
Statements
1 reference
Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up (English)
1 reference
1 reference
J F Arevalo
1 reference
L Wu
1 reference
J G Sanchez
1 reference
M J Saravia
1 reference
C F Fernandez
1 reference
T Evans
1 reference
21 September 2007
1 reference
1 reference
23
1 reference
1
1 reference
117-123
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference